Acutus Medical, Inc.: restructuring charge — Acutus Medical cuts 70% workforce (~61 employees) and transitions CEO to consulting role

Acutus Medical, Inc.

Workforce reduction of ~61 employees (~70%) expected to be completed by Q1 2025.
Pre-tax exit charges estimated $1.4M-$1.8M; majority cash outlay in Q1 2025.
CEO Takeo Mukai shifts to consulting role Feb 2025, retains titles, receives $10k/month.
Company scales down to only support Medtronic left-heart access obligations; earnout potential until 2027.
Cash on hand $12.6M as of Sep 30, 2024, expected to fund remaining business.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Acutus Medical, Inc. announced a restructuring with charges of approximately $1.4 million to $1.8 million of pre-tax downsizing and exit-related charges affecting left-heart access manufacturing and distribution business (approximately 61 employees, representing approximately 70% of the Company's employees).

Type: restructuring
Charge: approximately $1.4 million to $1.8 million of pre-tax downsizing and exit-related charges
Affected area: left-heart access manufacturing and distribution business
Headcount: approximately 61 employees, representing approximately 70% of the Company's employees

Exact text from the filing

The Company estimates it will incur approximately $1.4 million to $1.8 million of pre-tax downsizing and exit-related charges, of which approximately $0.3 million represents future cash expenditures for the payment of monetary consideration and related benefit costs, approximately $1.2 million represents future cash expenditures for the payment of retention bonuses to certain employees that will assist with the Downsizing, and potentially up to $0.3 million estimated as future cash expenditures for contract closing costs.

View on SEC.gov

Browse all restructurings & charges →

Source: SEC EDGAR

accession 0000950103-24-017271

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.